Skip to main content
Premium Trial:

Request an Annual Quote

BioTrove Raises $13.7M in Second Round of Financing

NEW YORK, April 15 (GenomeWeb News) - Biotrove has raised $13.7 million in a second round of financing, the company said today.


The Woburn, Mass.-based company will use the cash to commercialize its Living Chip SNP genotyping chip and Momentum assay development and screening platforms. BioTrove will also use the funds to support construction of a 10,000-square-foot manufacturing facility.


The round follows a first round of financing, announced in January. New investors in the second round included Echelon Ventures and Fletcher Spaght.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.